Development and use of specific ELISA methods for quantifying the biological activity of bevacizumab, cetuximab and trastuzumab in stability studies

  1. Suárez, I.
  2. Salmerón-García, A.
  3. Cabeza, J.
  4. Capitán-Vallvey, L.F.
  5. Navas, N.
Aldizkaria:
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

ISSN: 1873-376X 1570-0232

Argitalpen urtea: 2016

Alea: 1032

Orrialdeak: 155-164

Mota: Artikulua

DOI: 10.1016/J.JCHROMB.2016.05.045 GOOGLE SCHOLAR